ctrl K

Watchlist Price Alert

Acumen Pharmaceuticals In... (ABOS)

NASDAQ: ABOS · Real-Time Price · USD

1.17

0.03 (2.63%)

At close: Jun 17, 2025, 10:54 AM

Acumen Pharmaceuticals Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	35.63M	66.89M	130.1M	122.16M	43.78M	6.55M
Short-Term Investments	135.93M	176.64M	47.5M	72.08M	n/a	n/a
Long-Term Investments	59.97M	62.55M	15.84M	31.62M	n/a	n/a
Other Long-Term Assets	379K	454K	151K	14K	n/a	144K
Receivables	398K	225K	n/a	n/a	109K	30K
Inventory	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Assets	5.33M	1.96M	1.42M	2.83M	20K	547K
Total Current Assets	178.31M	246.62M	180.33M	198.66M	44.43M	7.18M
Property-Plant & Equipment	339K	503K	270K	36K	n/a	n/a
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	60.69M	63.51M	16.26M	31.67M	n/a	144K
Total Assets	238.99M	310.13M	196.59M	230.33M	44.43M	7.32M
Account Payables	5.65M	1.38M	1.64M	1.09M	531K	223K
Deferred Revenue	n/a	n/a	n/a	n/a	n/a	n/a
Short-Term Debt	133K	866K	105K	n/a	n/a	n/a
Other Current Liabilities	21.83M	6.17M	3.95M	2.96M	5.5M	614K
Total Current Liabilities	27.61M	12.97M	7.81M	5.15M	6.37M	1.34M
Long-Term Debt	29.42M	27.34M	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	970K	2.56M	n/a	n/a	56.65M	17.4M
Total Long-Term Liabilities	29.57M	30.18M	n/a	n/a	56.65M	17.4M
Total Liabilities	57.18M	43.15M	7.81M	5.15M	63.02M	18.74M
Total Debt	29.7M	28.49M	105K	n/a	n/a	n/a
Common Stock	6K	6K	4K	4K	n/a	n/a
Retained Earnings	-325.13M	-222.8M	-170.43M	-127.57M	-26.96M	-19.64M
Comprehensive Income	-48K	312K	-751K	-231K	n/a	n/a
Shareholders Equity	181.82M	266.97M	188.78M	225.18M	-18.59M	-11.42M
Total Investments	195.9M	239.19M	63.34M	103.69M	n/a	n/a